Official UK procurement notice
Varicella-zoster immunoglobulin (VZIG) 2025
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)
What is being bought4 lots · detail below
Published requirement descriptionContracts for the supply of immunoglobulin products
CPV: Immune sera and immunoglobulins
Lots and requirements (4)Procurement structure
4 lots · no lot values publishedLot #1Rabies immunoglobulin solution for injectionAwarded
Contract for the provision of Varicella-zoster immunoglobulin
Lot #2Human normal immunoglobulinAwarded
Contract for the provision of Human normal immunoglobulin. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
Lot #3Hepatitis B immunoglobulin 500IUAwarded
Contract for the provision of Hepatitis B immunoglobulin. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
Lot #4Varicella zoster immunoglobulin solution for injectionAwarded
Contract for the provision of Varicella zoster immunoglobulin solution for injection. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 8 Jul 2024, 14:40 BST
- Last source update
- 22 Apr 2026, 16:58 BST
- Award evaluation window
- 13 Aug 2024 – …
- FTS notice number
2026/S 000-036821- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-047b9eFind a Tender
Publisher note: The contract is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting product delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective immunisation programmes.
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Submission deadline
- 13 Aug 2024, 13:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 180 days from the deadline
- Bids opened
- 13 Aug 2024, 13:00 BST
Timeline
13 Aug 2024 → 22 Apr 2026 · 4 dates- Submission deadline13 Aug 2024, 13:00 BST
- Bids opened13 Aug 2024, 13:00 BST
- Contract starts1 May 2025, 00:00 BST
- Notice published177 days ago22 Apr 2026, 16:58 BST
Notice history
1 event · 5 releases on Find a Tender- Status changed to complete18 Mar 2025, 16:10 GMT
Published amendments (1 · 1 deadline change)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | DeadlineIV.2.2.1 | 13 Aug 2024 | 21 Aug 2024 | +8 d |
| — | Bid openingIV.2.7.1 | 13 Aug 2024 | 21 Aug 2024 | +8 d |
1 amendment published without a description.
Routine re-releases (5)
- 2024-08: 1 release · 7 Aug 2024
- 2024-07: 1 release · 8 Jul 2024
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Lot 1 · Rabies immunoglobulin solution for injection3 awards | |||
| BIO PRODUCTS LABORATORY LIMITED | — | — | Awarded |
| BIO PRODUCTS LABORATORY LIMITED | — | — | Awarded |
| Grifols UKSME | — | — | Awarded |
| Lot 2 · Human normal immunoglobulin1 award | |||
| Grifols UK | — | — | Awarded |
| Lot 3 · Hepatitis B immunoglobulin 500IU1 award | |||
| BIO PRODUCTS LABORATORY LIMITED | — | — | Awarded |
| Lot 4 · Varicella zoster immunoglobulin solution for injection1 award | |||
| Grifols UK | — | — | Awarded |
Contracts
Contract 009988-2025-2 · Grifols UK
- Signed
- 26 Feb 2025
- Value
- £1
- Status
- active
Contract 009988-2025-4 · Grifols UK
- Signed
- 26 Feb 2025
- Value
- £1
- Status
- active
Contract 036821-2026-C352339-1 · Grifols UKSME
- Signed
- 26 Feb 2025
- Value
- £1
- Period
- 1 May 2025 – 30 Apr 2027
- Status
- active
- Change Increase in product volume., Need for additional works, services or supplies by the original contractor/concessionaire: The Authority is invoking the contractual flexibility provisions to authorise an increase in the product volume.
Contract 009988-2025-1 · BIO PRODUCTS LABORATORY LIMITED
- Signed
- 19 Feb 2025
- Value
- £1
- Period
- … – 30 Apr 2027
- Status
- active
Contract 009988-2025-3 · BIO PRODUCTS LABORATORY LIMITED
- Signed
- 19 Feb 2025
- Value
- £1
- Status
- active
Contract 036820-2026-C352396-1 · BIO PRODUCTS LABORATORY LIMITED
- Signed
- 19 Feb 2025
- Value
- £1
- Period
- 1 May 2025 – 30 Apr 2027
- Status
- active
- Change The Authority is invoking the flexibility provision included within the contract., Need for additional works, services or supplies by the original contractor/concessionaire: The Authority is invoking the contractual flexibility provisions to authorise an increase in the product volume.
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Rabies immunoglobulin solution for injection | 1bids · 1 electronic | 0 | — | — |
| 2 · Human normal immunoglobulin | 1bids · 1 electronic | 0 | — | — |
| 3 · Hepatitis B immunoglobulin 500IU | 1bids · 1 electronic | 0 | — | — |
| 4 · Varicella zoster immunoglobulin solution for injection | 1bids · 1 electronic | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
4 commercial parties on the notice- BIO PRODUCTS LABORATORY LIMITEDAwarded supplier
- Bio Products Laboratory LtdAwarded supplier
- Grifols UK LimitedAwarded supplier
- Grifols UK Ltd.Awarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria